Investors may witness a significant increase in the price of Novo Nordisk
According to ten investors and market analysts surveyed, encouraging trial results indicating Novo Nordisk’s obesity medicine helps save and prolong lives, not merely lose weight, might drive up Europe’s better-performing stock even more. The United States’ booming demand for a Danish company’s weight-loss medication Wegovy prompted it to considerably increase its full-year profit and sales estimates last […]